IL17A and bacterial infectious disease: Then, using mouse models, we demonstrated that TRM17 cells persist in the tissue after bacterial infection and can rapidly respond to inflammatory stimuli, such as IL-1β by producing IL-17A, which ultimately aggravates immune-mediated tissue injury (16).